BridgeMD
New treatment option for Microvascular Angina
Official title iCorMicA - Stratified Medicine in Angina
ClinicalTrials.gov ID: NCT04674449
What this study is testing
- What it's testing
- The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine whether stratified medical therapy guided by an adjunctive interventional diagnostic procedure (IDP) during the invasive management of patients with known or suspected angina but no obstructive coronary artery disease improves symptoms, wellbeing, cardiovascular risk and clinical outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years.
- A clinical plan for invasive coronary angiography.
- Symptoms of angina (typical or atypical) according to the Rose- and/or Seattle Angina questionnaires.
- Able to comply with study procedures.
- Able to provide informed consent.
You likely can't join if
- A non-coronary primary indication for invasive angiography (e.g. valve disease, heart failure).
- History of coronary artery bypass surgery.
- Presence of obstructive disease evident in a main coronary artery (diameter \>2.5 mm), i.e. a coronary stenosis \>50% and/or a fractional flow...
- Logistical reason\ . \ These patients will enter a follow-up registry.
The study team makes the final eligibility decision.
Where it's taking place
- Cork, Ireland
- Dublin, Ireland
- Nijmegen, Netherlands
- Krakow, Poland
- Clydebank, Scotland, United Kingdom
- Aberdeen, United Kingdom
- Ashford, United Kingdom
- Basildon, United Kingdom
- Bedford, United Kingdom
- Belfast, United Kingdom
- Birmingham, United Kingdom
- Blackburn, United Kingdom
- Blackpool, United Kingdom
- Bodelwyddan, United Kingdom
- Bournemouth, United Kingdom
- Cambridge, United Kingdom
- Cardiff, United Kingdom
- Chertsey, United Kingdom
- Coventry, United Kingdom
- East Kilbride, United Kingdom
+ 16 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cork, Ireland; Dublin, Ireland; Nijmegen, Netherlands; Krakow, Poland; Clydebank, Scotland, United Kingdom; Aberdeen, United Kingdom and 30 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.